Linrodostat

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Linrodostat
Accession Number
DB14986
Type
Small Molecule
Groups
Investigational
Description

Linrodostat is under investigation in clinical trial NCT03247283 (Pharmacokinetics and Metabolism Study in Healthy Male Participants).

Structure
Thumb
Synonyms
  • BMS-986205
Categories
UNII
0A7729F42K
CAS number
1923833-60-6
Weight
Average: 410.92
Monoisotopic: 410.1561193
Chemical Formula
C24H24ClFN2O
InChI Key
KRTIYQIPSAGSBP-ZACQAIPSSA-N
InChI
InChI=1S/C24H24ClFN2O/c1-15(24(29)28-20-9-6-18(25)7-10-20)16-2-4-17(5-3-16)21-12-13-27-23-11-8-19(26)14-22(21)23/h6-17H,2-5H2,1H3,(H,28,29)/t15-,16-,17+/m1/s1
IUPAC Name
SMILES
C[C@H]([C@H]1CC[C@H](CC1)C1=C2C=C(F)C=CC2=NC=C1)C(=O)NC1=CC=C(Cl)C=C1

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
ChemSpider
58828674
HET
H7P
PDB Entries
6dpq / 6dpr / 6mq6

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1Active Not RecruitingBasic ScienceHealthy Volunteers1
1CompletedBasic ScienceHealthy Volunteers1
1CompletedHealth Services ResearchMalignancies1
1CompletedOtherHealthy Participants1
1CompletedOtherMalignancies Multiple1
1CompletedTreatmentCancer, Advanced1
1CompletedTreatmentHealthy Volunteers1
1RecruitingTreatmentCancer, Advanced1
1, 2RecruitingTreatmentCancer, Advanced2
1, 2RecruitingTreatmentCancer, Advanced / Lung Cancer Non-Small Cell Cancer (NSCLC) / Melanoma1
1, 2RecruitingTreatmentMetastatic Hepatocellular Carcinoma / Stage III Hepatocellular Carcinoma AJCC v8 / Stage IIIA Hepatocellular Carcinoma AJCC v8 / Stage IIIB Hepatocellular Carcinoma AJCC v8 / Stage IV Hepatocellular Carcinoma AJCC v8 / Stage IVA Hepatocellular Carcinoma AJCC v8 / Stage IVB Hepatocellular Carcinoma AJCC v8 / Unresectable Hepatocellular Carcinoma1
2Active Not RecruitingTreatmentCancer, Advanced1
2Not Yet RecruitingTreatmentMelanoma Stage Iii / Melanoma Stage Iv1
2RecruitingTreatmentAdvanced Gastric Cancer1
2RecruitingTreatmentBladder Cancers / Bladder Tumors / Neoplasms, Bladder1
2RecruitingTreatmentCancer, Advanced1
2RecruitingTreatmentLarynx / LIP / Oral Cavity Squamous Cell Carcinoma / Pharynx / Squamous Cell Carcinoma (SCC)1
3Active Not RecruitingTreatmentMelanoma / Skin Cancers1
3RecruitingTreatmentBladder Cancers / BMS-986205 / Muscle-invasive Bladder Cancer1
3WithdrawnTreatmentHead and Neck Carcinoma1
3WithdrawnTreatmentLung Cancer Non-Small Cell Cancer (NSCLC) / Lung Cancers1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Taxonomy

Classification
Not classified

Drug created on May 20, 2019 08:39 / Updated on May 21, 2019 12:33